Your browser doesn't support javascript.
loading
Convenient route to Fmoc-homotyrosine via metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptides.
Bérubé, Christopher; Guay, Louis-David; Fraser, Tommy; Lapointe, Victor; Cardinal, Sébastien; Biron, Éric.
Affiliation
  • Bérubé C; Faculté de Pharmacie, Université Laval, Québec, Québec, Canada, G1 V 0A6. eric.biron@pha.ulaval.ca.
  • Guay LD; Laboratory of Medicinal Chemistry, Centre de Recherche du CHU de Québec-Université Laval, 2705 Boulevard Laurier, Québec, Québec, Canada, G1 V 0A6.
  • Fraser T; Faculté de Pharmacie, Université Laval, Québec, Québec, Canada, G1 V 0A6. eric.biron@pha.ulaval.ca.
  • Lapointe V; Laboratory of Medicinal Chemistry, Centre de Recherche du CHU de Québec-Université Laval, 2705 Boulevard Laurier, Québec, Québec, Canada, G1 V 0A6.
  • Cardinal S; Département de Biologie, Chimie et Géographie, Université du Québec à Rimouski, 300 allée des Ursulines, Rimouski, Québec, Canada, G5L 3A1.
  • Biron É; Faculté de Pharmacie, Université Laval, Québec, Québec, Canada, G1 V 0A6. eric.biron@pha.ulaval.ca.
Org Biomol Chem ; 21(45): 9011-9020, 2023 11 22.
Article in En | MEDLINE | ID: mdl-37921761
Herein, we report the first solid-phase total synthesis of the natural cyclic peptide anabaenopeptin F and the use of metallaphotoredox catalysis to overcome the key challenges associated with the preparation of the non-proteinogenic amino acid homotyrosine contained in these peptides. Starting from L-homoserine, enantiopure Fmoc-protected homotyrosine was prepared in a straightforward manner by metallaphotoredox catalysis with N-Fmoc-(S)-2-amino-4-bromobutanoic acid and 4-tert-butoxybromobenzene partners. The prepared protected amino acid was used in solid-phase peptide synthesis to achieve the total synthesis of anabaenopeptin F and establish the stereochemistry of the isoleucine residue. Protease inhibition studies with the synthesized anabaenopeptin F showed inhibitory activities against carboxypeptidase B in the low nanomolar range. The high convergency of the synthetic methodologies paves the way for the rapid access to N-Fmoc-protected non-proteinogenic and unnatural amino acids and the total synthesis of complex bioactive peptides containing these amino acids.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Peptides, Cyclic Language: En Journal: Org Biomol Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Peptides, Cyclic Language: En Journal: Org Biomol Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2023 Type: Article